Next Article in Journal
Understanding the Functions of Long Non-Coding RNAs through Their Higher-Order Structures
Next Article in Special Issue
MicroRNA-24 Attenuates Neointimal Hyperplasia in the Diabetic Rat Carotid Artery Injury Model by Inhibiting Wnt4 Signaling Pathway
Previous Article in Journal
Passive Immune-Protection of Litopenaeus vannamei against Vibrio harveyi and Vibrio parahaemolyticus Infections with Anti-Vibrio Egg Yolk (IgY)-Encapsulated Feed
Previous Article in Special Issue
Thrombin Receptor-Activating Protein (TRAP)-Activated Akt Is Involved in the Release of Phosphorylated-HSP27 (HSPB1) from Platelets in DM Patients
Review

Postprandial C-Peptide to Glucose Ratio as a Marker of β Cell Function: Implication for the Management of Type 2 Diabetes

Department of Internal Medicine, Keio University School of Medicine, 1608582 Tokyo, Japan
Academic Editor: Toshiro Arai
Int. J. Mol. Sci. 2016, 17(5), 744; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms17050744
Received: 30 March 2016 / Revised: 7 May 2016 / Accepted: 11 May 2016 / Published: 17 May 2016
(This article belongs to the Special Issue Molecular Research on Obesity and Diabetes)
C-peptide is secreted from pancreatic β cells at an equimolar ratio to insulin. Since, in contrast to insulin, C-peptide is not extracted by the liver and other organs, C-peptide reflects endogenous insulin secretion more accurately than insulin. C-peptide is therefore used as a marker of β cell function. C-peptide has been mainly used to assess the presence of an insulin-dependent state for the diagnosis of type 1 diabetes. However, recent studies have revealed that β cell dysfunction is also a core deficit of type 2 diabetes, and residual β cell function is a key factor in achieving optimal glycemic control in patients with type 2 diabetes. This review summarizes the role of C-peptide, especially the postprandial C-peptide to glucose ratio which likely better reflects maximum β cell secretory capacity compared with the fasting ratio in assessing β cell function, and discusses perspectives on its clinical utility for managing glycemic control in patients with type 2 diabetes. View Full-Text
Keywords: C-peptide; type 2 diabetes; β cell function; postprandial C-peptide; type 2 diabetes; β cell function; postprandial
Show Figures

Figure 1

MDPI and ACS Style

Saisho, Y. Postprandial C-Peptide to Glucose Ratio as a Marker of β Cell Function: Implication for the Management of Type 2 Diabetes. Int. J. Mol. Sci. 2016, 17, 744. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms17050744

AMA Style

Saisho Y. Postprandial C-Peptide to Glucose Ratio as a Marker of β Cell Function: Implication for the Management of Type 2 Diabetes. International Journal of Molecular Sciences. 2016; 17(5):744. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms17050744

Chicago/Turabian Style

Saisho, Yoshifumi. 2016. "Postprandial C-Peptide to Glucose Ratio as a Marker of β Cell Function: Implication for the Management of Type 2 Diabetes" International Journal of Molecular Sciences 17, no. 5: 744. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms17050744

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop